| Year |
Citation |
Score |
| 2023 |
Baron F, Nagler A, Galimard JE, Sanz J, Versluis J, Forcade E, Chevallier P, Sirvent A, Anthias C, Kuball J, Furst S, Rambaldi A, Sierra J, von dem Borne PA, Gallego Hernanz MP, et al. Cord blood transplantation for AML: Comparable LFS in patients with de novo versus secondary AML in CR1, an ALWP/EBMT study. British Journal of Haematology. PMID 37784256 DOI: 10.1111/bjh.19130 |
0.339 |
|
| 2022 |
Nagler A, Labopin M, Cornelissen JJ, Forcade E, Chevallier P, Fegueux N, Sierra J, Desmier D, Labussière-Wallet H, Byrne JL, Loschi M, Blaise D, Baron F, Ruggeri A, Mohty M. Outcome of human umbilical cord blood stem cell transplantation (CBT) for acute myeloid leukemia in patients achieving first complete remission after one versus two induction courses: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplantation. PMID 35773347 DOI: 10.1038/s41409-022-01742-2 |
0.315 |
|
| 2020 |
Sheth V, Volt F, Sanz J, Clement L, Cornelissen J, Blaise D, Sierra J, Michallet M, Saccardi R, Rocha V, Gluckman E, Chabannon C, Ruggeri A. Reduced-intensity versus myeloablative conditioning in cord blood transplantation for AML (40-60 years) across highly mismatched HLA barriers - On behalf of Eurocord and the Cellular Therapy & Immunobiology Working Party (CTIWP) of EBMT. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 32726672 DOI: 10.1016/j.bbmt.2020.07.025 |
0.322 |
|
| 2020 |
Baron F, Labopin M, Ruggeri A, Sierra J, Robinson S, Labussière-Wallet H, Potter M, Ribera JM, Deconinck E, Rambaldi A, Rohrlich PS, de Revel T, Gluckman E, Nagler A, Mohty M. Impact of detectable measurable residual disease on umbilical cord blood transplantation. American Journal of Hematology. PMID 32449964 DOI: 10.1002/ajh.25879 |
0.316 |
|
| 2020 |
Díaz-Beyá M, Labopin M, Maertens J, Alijurf M, Passweg J, Dietrich B, Schouten H, Socié G, Schaap N, Schwerdtfeger R, Volin L, Michallet M, Polge E, Sierra J, Mohty M, et al. Allogeneic stem cell transplantation in AML with t(6;9)(p23;q34);DEK-NUP214 shows a favourable outcome when performed in first complete remission. British Journal of Haematology. PMID 32020596 DOI: 10.1111/bjh.16433 |
0.322 |
|
| 2019 |
Penack O, Peczynski C, van der Werf S, Finke J, Ganser A, Schoemans H, Pavlu J, Niittyvuopio R, Schroyens W, Kaynar L, Blau IW, van der Velden W, Sierra J, Cortelezzi A, Wulf G, et al. Association of uric acid levels before start of conditioning with mortality after alloSCT: a prospective, non-interventional study of the EBMT Transplant Complication Working Party. Haematologica. PMID 31601686 DOI: 10.3324/haematol.2019.228668 |
0.339 |
|
| 2019 |
Novelli S, Bento L, García-Cadenas I, Prieto L, Corral LL, Gutierrez Garcia G, Hernani R, Pérez Martínez A, Sierra J, Solano C, Bastos-Oreiro M, Dorado N, Rodríguez-Torres N, Rodríguez G, Piñana Sanchez JL, et al. Allogeneic Hematopoietic Stem Cell Transplantation for T Cell Lymphomas: Improved Results Overtime Blood. 134: 3325-3325. DOI: 10.1182/blood-2019-126507 |
0.309 |
|
| 2018 |
Ortí G, Sanz J, García-Cadenas I, Sánchez-Ortega I, Alonso L, Jiménez MJ, Sisinni L, Azqueta C, Salamero O, Badell I, Ferra C, Diaz de Heredia C, Parody R, Sanz MA, Sierra J, et al. Analysis of relapse post transplant in acute leukemia, a comparative on second allogeneic hematopoietic cell transplant and donor lymphocyte infusions. Experimental Hematology. PMID 29526774 DOI: 10.1016/j.exphem.2018.03.002 |
0.35 |
|
| 2018 |
Bazarbachi A, Boumendil A, Finel H, Mohty M, Castagna L, Peggs KS, Blaise D, Afanasyev B, Diez-Martin JL, Sierra J, Bloor A, Martinez C, Robinson S, Malladi R, El-Cheikh J, et al. Brentuximab vedotin prior to allogeneic stem cell transplantation in Hodgkin lymphoma: a report from the EBMT Lymphoma Working Party. British Journal of Haematology. PMID 29468647 DOI: 10.1111/bjh.15152 |
0.331 |
|
| 2018 |
Robinson SP, Boumendil A, Finel H, Peggs KS, Chevallier P, Sierra J, Finke J, Poiré X, Maillard N, Milpied N, Yakoub-Agha I, Koh M, Kröger N, Nagler A, Koc Y, et al. Long-term outcome analysis of reduced-intensity allogeneic stem cell transplantation in patients with mantle cell lymphoma: a retrospective study from the EBMT Lymphoma Working Party. Bone Marrow Transplantation. PMID 29335632 DOI: 10.1038/s41409-017-0067-3 |
0.307 |
|
| 2018 |
Barba P, Martino R, Zhou Q, Cho C, Castro-Malaspina H, Devlin S, Esquirol A, Giralt S, Jakubowski AA, Caballero D, Maloy M, Papadopoulos EB, Piñana JL, Fox ML, Márquez F, ... ... Sierra J, et al. CD34+ Selection Vs. Reduced-Intensity Conditioning and Unmodified Graft for Allogeneic Hematopoietic Cell Transplantation in Patients with AML and MDS > 50 Years. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 29305194 DOI: 10.1016/J.Bbmt.2017.12.804 |
0.301 |
|
| 2018 |
De Lavallade H, Sbianchi G, Koster L, Sanz J, Angelucci E, Socie G, Pietri I, Labussière-Wallet H, Cornelissen JJ, Gedde-Dahl T, Petersen EJ, Bonifazi F, Sierra J, Carre M, Marchand T, et al. Outcomes after Unrelated Cord Blood Transplantation (UCBT) in Patients with Chronic Myeloid Leukemia (CML): A Retrospective Study from the Cmwp-EBMT Blood. 132: 3475-3475. DOI: 10.1182/BLOOD-2018-99-115977 |
0.326 |
|
| 2017 |
Savani BN, Boumendil A, Labopin M, Finke J, Stelljes M, Ganser A, Wulf G, Volin L, Martin S, Blaise D, Maertens J, Bourhis J, Yañez L, Sierra J, Fegueux N, et al. Myeloablative Versus Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation for Secondary Acute Myeloid Leukemia in Patients with Prior Myelodysplastic Syndrome/ Myeloproliferative Disorders: An ALWP of EBMT Study Blood. 130: 907-907. DOI: 10.1182/BLOOD.V130.SUPPL_1.907.907 |
0.357 |
|
| 2016 |
Orti G, García-Cadenas I, Sánchez-Ortega I, Jimenez MJ, Alonso L, Azqueta C, Diaz de Heredia C, Ferra C, Parody R, Sierra J, Querol S, Valcarcel D. Donor Lymphocyte Infusions for Haematological Malignancy Relapse Blood. 128: 5775-5775. DOI: 10.1182/blood.V128.22.5775.5775 |
0.332 |
|
| 2015 |
Orti G, Sanz J, Bermudez A, Caballero D, Martinez C, Sierra J, Cabrera Marin JR, Espigado I, Solano C, Ferrà C, García-Noblejas A, Jimenez S, Sampol A, Yañez L, Garcia V, et al. Outcome of second allogeneic HCT following relapse of myeloid malignancies post allogeneic HCT, a retrospective cohort on behalf of the GETH. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 26631751 DOI: 10.1016/j.bbmt.2015.11.012 |
0.318 |
|
| 2015 |
Castillo N, García-Cadenas I, Barba P, Martino R, Azqueta C, Ferrà C, Canals C, Sierra J, Valcárcel D, Querol S. Post-Thaw Viable CD45(+) Cells and Clonogenic Efficiency are Associated with Better Engraftment and Outcomes after Single Cord Blood Transplantation in Adult Patients with Malignant Diseases. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 26319094 DOI: 10.1016/j.bbmt.2015.08.016 |
0.305 |
|
| 2015 |
Ruggeri A, Labopin M, Sanz G, Piemontese S, Arcese W, Bacigalupo A, Blaise D, Bosi A, Huang H, Karakasis D, Koc Y, Michallet M, Picardi A, Sanz J, Santarone S, ... ... Sierra J, et al. Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantation in adults with acute leukemia. Leukemia. PMID 25882700 DOI: 10.1038/leu.2015.98 |
0.343 |
|
| 2015 |
Martinez C, Gayoso J, Canals C, Finel H, Bacigalupo A, Peggs K, Milpied N, Ciceri F, Socie G, Corradini P, Robinson S, Velardi A, Fegueux N, Gutierrez G, Mackinnon S, ... ... Sierra J, et al. Alternative Donors (Umbilical Cord Blood and Haploidentical Donors) for Allogeneic Stem Cell Transplantation in Relapsed / Refractory Hodgkin Lymphoma: A Retrospective Analysis of the EBMT Lymphoma Working Party and the Spanish Group of Stem Cell Transplantation (GETH) Blood. 126: 4399-4399. DOI: 10.1182/BLOOD.V126.23.4399.4399 |
0.341 |
|
| 2014 |
Onida F, Brand R, van Biezen A, Schaap M, von dem Borne PA, Maertens J, Beelen DW, Carreras E, Alessandrino EP, Volin L, Kuball JH, Figuera A, Sierra J, Finke J, Kröger N, et al. Impact of the International Prognostic Scoring System cytogenetic risk groups on the outcome of patients with primary myelodysplastic syndromes undergoing allogeneic stem cell transplantation from human leukocyte antigen-identical siblings: a retrospective analysis of the European Society for Blood and Marrow Transplantation-Chronic Malignancies Working Party. Haematologica. 99: 1582-90. PMID 25085359 DOI: 10.3324/haematol.2014.106880 |
0.32 |
|
| 2014 |
Bonifazi F, Solano C, Wolschke C, Patriarca F, Pini M, Nagler A, Selleri M, Messina G, Bethge WA, Fuente PH, Duarte RF, Cascavilla N, Cimminiello M, Guidi S, Finke J, ... ... Sierra J, et al. Prevention of Chronic GvHD after HLA-Identical Sibling Peripheral Hematopietic Stem Cell Transplantation with or without Anti-Lymphocyte Globulin (ATG). Results from a Prospective, Multicenter Randomized Phase III Trial (ATGfamilystudy) Blood. 124: 37-37. DOI: 10.1182/BLOOD.V124.21.37.37 |
0.337 |
|
| 2014 |
Ruggeri A, Labopin M, Sanz GF, Piemontese S, Arcese W, Bacigalupo A, Blaise D, Bosi A, Huang H, Karakasis D, Koc Y, Michallet M, Picardi A, Sanz J, Santarone S, ... ... Sierra J, et al. Unrelated Cord Blood Versus Non-T Cell Depleted Haploidentical Stem Cell Transplantation: Comparable Results in Adults with Acute Leukemia, a Eurocord and ALWP-EBMT Study Blood. 124: 1227-1227. DOI: 10.1182/BLOOD.V124.21.1227.1227 |
0.361 |
|
| 2013 |
Novelli S, Esquirol A, Briones J, Leoz P, Martino R, Ana G, Garcia I, Silvana S, Granell M, Moreno C, Brunet S, Sierra J. Long-Term Follow-Up Of Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation For High Risk Follicular Lymphoma Blood. 122: 5519-5519. DOI: 10.1182/BLOOD.V122.21.5519.5519 |
0.307 |
|
| 2008 |
Delgado J, Pillai S, Benjamin R, Caballero D, Martino R, Nathwani A, Lovell R, Thomson K, Perez-Simon JA, Sureda A, Kottaridis P, Vazquez L, Peggs K, Sierra J, Milligan D, et al. The effect of in vivo T cell depletion with alemtuzumab on reduced-intensity allogeneic hematopoietic cell transplantation for chronic lymphocytic leukemia. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 14: 1288-97. PMID 18940684 DOI: 10.1016/j.bbmt.2008.09.001 |
0.355 |
|
| 2008 |
Schlenk RF, Pasquini MC, Pérez WS, Zhang MJ, Krauter J, Antin JH, Bashey A, Bolwell BJ, Büchner T, Cahn JY, Cairo MS, Copelan EA, Cutler CS, Döhner H, Gale RP, ... ... Sierra J, et al. HLA-identical sibling allogeneic transplants versus chemotherapy in acute myelogenous leukemia with t(8;21) in first complete remission: collaborative study between the German AML Intergroup and CIBMTR. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 14: 187-96. PMID 18215779 DOI: 10.1016/j.bbmt.2007.10.006 |
0.325 |
|
| 2008 |
Piñana JL, Valcarcel D, Martino R, Fernandez F, Barba P, Rovira M, Carreras E, Sureda A, Sierra J. Cyclosporine a and Mycophenolate Mofetil Vs Cyclosporine a and Methotrexate as Gvhd Prophylaxis in Reduced Intensity Conditioning Hematopoietic Stem Cell Transplantation from HLA-Identical Sibling Donor. Blood. 112: 2229-2229. DOI: 10.1182/BLOOD.V112.11.2229.2229 |
0.313 |
|
| 2007 |
Peggs KS, Sureda A, Qian W, Caballero D, Hunter A, Urbano-Ispizua A, Cavet J, Ribera JM, Parker A, Canales M, Mahendra P, Garcia-Conde J, Milligan D, Sanz G, Thomson K, ... ... Sierra J, et al. Reduced-intensity conditioning for allogeneic haematopoietic stem cell transplantation in relapsed and refractory Hodgkin lymphoma: Impact of alemtuzumab and donor lymphocyte infusions on long-term outcomes British Journal of Haematology. 139: 70-80. PMID 17854309 DOI: 10.1111/J.1365-2141.2007.06759.X |
0.333 |
|
| 2007 |
Delgado J, Marco A, Moreno E, Pinana JL, Valcarcel D, Parody R, Sanchez-Gonzalez B, Martino R, Briones J, Sureda A, Brunet S, Sierra J. Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation Using Oral Fludarabine as Part of the Conditioning Regimen. Blood. 110: 4925-4925. DOI: 10.1182/BLOOD.V110.11.4925.4925 |
0.309 |
|
| 2007 |
Marks DI, Pérez WS, He V, Zhang M, Keating A, Tallman M, Sierra J, Weisdorf D. Unrelated Donor (URD) Hematopoietic Stem Cell Transplantation (HCT) for Adults with Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia (ALL) in First Complete Remission (CR1): A Center for International Blood and Marrow Transplant Research (CIBMTR) Analysis. Blood. 110: 3055-3055. DOI: 10.1182/Blood.V110.11.3055.3055 |
0.331 |
|
| 2007 |
Delgado J, Pillai S, Benjamin R, Caballero D, Martino R, Lovell R, Thomson K, Perez-Simon JA, Sureda A, Kottaridis P, Miguel JS, Peggs K, Sierra J, Milligan D, Mackinnon S. The Effect of In Vivo T-Cell Depletion with Alemtuzumab on Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation for Chronic Lymphocytic Leukemia. Blood. 110: 3014-3014. DOI: 10.1182/BLOOD.V110.11.3014.3014 |
0.34 |
|
| 2007 |
Brunet S, Labopin M, Cornelissen JJ, Socié G, Iori AP, Verdonck LF, Ruutu T, Gratwohl A, Harousseau J, Sierra J, Rocha V. Impact of FLT3 Internal Tandem Duplication (FLT3/ITD) on the Outcome of HLA-Identical Sibling Hematopoietic Transplantation for Adult Acute Myeloid Leukemia (AML) in First Remission: Substantial Probability of Leukemia-Free Survival Despite Increased Relapse Risk. A Retrospective Analysis of the EBMT-ALWP. Blood. 110: 1088-1088. DOI: 10.1182/blood.v110.11.1088.1088 |
0.343 |
|
| 2006 |
Martino R, Iacobelli S, Brand R, Jansen T, van Biezen A, Finke J, Bacigalupo A, Beelen D, Reiffers J, Devergie A, Alessandrino E, Mufti GJ, Barge R, Sierra J, Ruutu T, et al. Retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic hematopoietic stem cell transplantation using HLA-identical sibling donors in myelodysplastic syndromes. Blood. 108: 836-46. PMID 16597592 DOI: 10.1182/BLOOD-2005-11-4503 |
0.316 |
|
| 2006 |
Alvarez I, Sureda A, Caballero MD, Urbano-Ispizua A, Ribera JM, Canales M, García-Conde J, Sanz G, Arranz R, Bernal MT, de la Serna J, Díez JL, Moraleda JM, Rubió-Félix D, Xicoy B, ... ... Sierra J, et al. Nonmyeloablative stem cell transplantation is an effective therapy for refractory or relapsed hodgkin lymphoma: results of a spanish prospective cooperative protocol. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 12: 172-83. PMID 16443515 DOI: 10.1016/J.Bbmt.2005.09.009 |
0.326 |
|
| 2006 |
Carreras E, Jiménez M, Gómez-García V, de la Cámara R, Martín C, Martínez F, Iriondo A, Sanz G, Cañizo C, Cabrera R, Sierra J, Vallejo C, López J, Martínez C, Rovira M, et al. Donor age and degree of HLA matching have a major impact on the outcome of unrelated donor haematopoietic cell transplantation for chronic myeloid leukaemia. Bone Marrow Transplantation. 37: 33-40. PMID 16247421 DOI: 10.1038/sj.bmt.1705195 |
0.306 |
|
| 2004 |
Diez-Campelo M, Perez-Simon JA, Martino R, Valcarce D, Urbano A, Caballero DM, Leon A, Brunet S, Carreras E, Cañizo CM, Sierra J, San Miguel JF. Influence of the Intensity of the Conditioning Regimen on the Characteristics of Acute and Chronic Graft Versus Host Disease after Allogeneic Transplantation. Blood. 104: 5157-5157. DOI: 10.1182/blood.v104.11.5157.5157 |
0.329 |
|
| 1997 |
Sierra J, Storer B, Hansen JA, Bjerke JW, Martin PJ, Petersdorf EW, Appelbaum FR, Bryant E, Chauncey TR, Sale G, Sanders JE, Storb R, Sullivan KM, Anasetti C. Transplantation of Marrow Cells From Unrelated Donors for Treatment of High-Risk Acute Leukemia: The Effect of Leukemic Burden, Donor HLA-Matching, and Marrow Cell Dose Blood. 89: 4226-4235. DOI: 10.1182/BLOOD.V89.11.4226 |
0.305 |
|
| 1991 |
Papazoglou G, Sierra J, Homberger K, Guggisberg A, Woggon W, Hesse M. Biosynthesis of the Spermine Alkaloid Aphelandrine Helvetica Chimica Acta. 74: 565-571. DOI: 10.1002/Hlca.19910740313 |
0.477 |
|
| Show low-probability matches. |